IBS Rates Nearly Doubled During the Pandemic
By Dennis Thompson HealthDay Reporter
MONDAY, July 1, 2025 — The COVID-19 pandemic took a toll on Americans’ guts, researchers report.
Gut disorders like irritable bowel syndrome (IBS) increased significantly during the COVID-19 pandemic, a new study says.
Rates of IBS nearly doubled among U.S. adults, rising from around 6% in May 2020 to about 11% in May 2022, results show.
Other gut health problems like constipation also increased, researchers report in the journal Neurogastroenterology & Motility.
“Rates of digestive issues such as irritable bowel syndrome and chronic idiopathic constipation rose significantly,” lead researcher Dr. Christopher Almario, a gastroenterologist at Cedars-Sinai Medical Center in Los Angeles, said in a news release.
“These findings underscore the significant toll the pandemic has taken on digestive health,” Almario added.
Conditions like IBS and chronic constipation are driven by complex interactions between the gut and the nervous system, researchers said in background notes.
“These disorders involve chronic gastrointestinal symptoms that are often triggered or worsened by psychological stress,” Almario said.
Researchers figured that more people might have developed a gut health disorder during the pandemic, from the effect of COVID infection on the digestive system as well as the stress from social distancing, isolation and fear of infection.
For the study, researchers analyzed data from more than 160,000 U.S. adults who participated in a national online survey from May 2020 to May 2022. Participants completed questionnaires covering digestive symptoms, mental health and lifestyle changes.
People with IBS most commonly reported suffering from mixed IBS, a type where the patient has both diarrhea and constipation, results show.
“This research calls for a renewed focus on gastrointestinal health in the post-pandemic era,” senior researcher Dr. Brennan Spiegel, director of health services research for Cedars-Sinai, said in a news release.
Sources
- Cedars-Sinai, news release, June 27, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Further Support and Information on COVID-19
Read this next
Vitamin D Might Offer Protection Against COVID-19
FRIDAY, July 25, 2025 — Low vitamin D levels might increase a person’s odds of a severe bout with COVID-19, a new study says. People with a vitamin D deficiency are...
COVID Boosters Protect People With Cancer
WEDNESDAY, July 23, 2025 — Cancer patients can be very vulnerable to a severe COVID infection, but COVID-19 vaccine boosters can be lifesavers for them, a new study...
For Some, Gluten Intolerance Is Psychological, Study Says
TUESDAY, July 22, 2025 — Gluten intolerance might be all in the minds of some people with irritable bowel syndrome (IBS), results from a small-scale experiment...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.